What: More than 8,000 researchers, health care professionals and advocates will attend the 33rd Annual San Antonio Breast Cancer Symposium at the The Cancer Therapy & Research Center, now part of the UT Health Science Center, started the symposium. In recent years, it has brought on co-sponsors Baylor College of Medicine in Houston and the American Association for Cancer Research.
Who: Presenters and moderators will include several faculty members from The University of Texas Health Science Center at San Antonio.
Where: Henry B. Gonzalez Convention Center
When: Dec. 8-12
Why: The symposium offers the latest information both for basic scientists and clinicians who work directly with patients. The symposium also provides a forum where those two groups can interact and exchange information. Here researchers will reveal complex and carefully vetted scientific studies to advance the understanding and treatment cancer. At this point the information in those studies is still under embargo.
Topic of interest on Wednesday: From 2 – 3:30 p.m. a panel of experts in Ballroom C2 will address the subject of genetic predisposition to breast cancer. Many women who learn they are genetically predisposed to breast cancer have chosen preventive mastectomies. Martha Thomas, genetic counselor at The University of Texas Health Science Center at San Antonio, will be attending the discussion and is available for interviews.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.